Trials / Recruiting
RecruitingNCT07455136
A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury
A Multicenter Prospective Study to Develop a Blood-based Biomarker Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adult Subjects (CLIN12.1) and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury (CLIN12.2)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is intended to cover two purposes: first, to develop a blood-based biomarker test for aiding the diagnosis of traumatic brain injury (TBI) in adult participants and for prognosis of outcome of TBI (CLIN12.1); and second, for monitoring the development of secondary events in adult participants diagnosed with TBI (CLIN12.2).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood sample collection | Blood samples from each enrolled participant in CLIN12.1 and/or CLIN12.2 will be collected. |
Timeline
- Start date
- 2026-02-09
- Primary completion
- 2028-03-31
- Completion
- 2028-05-31
- First posted
- 2026-03-06
- Last updated
- 2026-04-03
Locations
11 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT07455136. Inclusion in this directory is not an endorsement.